5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol

C125H135Br5N21O10+ — CID 172961503

IUPAC5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
SMILESCC(C)CC[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CC(CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21)Cc1ccccn1.CC1CCC(C(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CN(C)CCN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CN1CCC(N(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1
InChIInChI=1S/C27H30BrN3O2.C26H23BrN4O2.C25H28BrN5O2.C24H27BrN4O2.C23H26BrN5O2/c1-16-7-9-18(10-8-16)17(2)13-14-33-31-25-20-5-3-4-6-22(20)29-26(25)24-21-15-19(28)11-12-23(21)30-27(24)32;1-16(14-18-6-4-5-12-28-18)11-13-33-31-24-19-7-2-3-8-21(19)29-25(24)23-20-15-17(27)9-10-22(20)30-26(23)32;1-30-11-9-17(10-12-30)31(2)13-14-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-15-16(26)7-8-21(19)28-25(22)32;1-15(2)10-11-29(3)12-13-31-28-22-17-6-4-5-7-19(17)26-23(22)21-18-14-16(25)8-9-20(18)27-24(21)30;1-28(2)10-11-29(3)12-13-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-14-15(24)8-9-19(17)26-23(20)30/h3-6,11-12,15-18,30,32H,7-10,13-14H2,1-2H3;2-10,12,15-16,30,32H,11,13-14H2,1H3;3-8,15,17,28,32H,9-14H2,1-2H3;4-9,14-15,27,30H,10-13H2,1-3H3;4-9,14,26,30H,10-13H2,1-3H3/p+1/b31-25+;31-24+;29-23+;28-22+;27-21+
InChIKeyIFVICHNYNKEXCB-NNMPHZAYSA-O
MW2491.11 g/mol
LogP26.05
Rot. Bonds35

About 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol

5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol (PubChem CID 172961503) has the molecular formula C125H135Br5N21O10+ and a molecular weight of 2491.11 g/mol. Its IUPAC name is 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol.

Molecular Properties

Compound Name5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
PubChem CID172961503
Molecular FormulaC125H135Br5N21O10+
Molecular Weight2491.11 g/mol
Exact Mass2484.66
IUPAC Name5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
SMILESCC(C)CC[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CC(CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21)Cc1ccccn1.CC1CCC(C(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CN(C)CCN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CN1CCC(N(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1
InChIInChI=1S/C27H30BrN3O2.C26H23BrN4O2.C25H28BrN5O2.C24H27BrN4O2.C23H26BrN5O2/c1-16-7-9-18(10-8-16)17(2)13-14-33-31-25-20-5-3-4-6-22(20)29-26(25)24-21-15-19(28)11-12-23(21)30-27(24)32;1-16(14-18-6-4-5-12-28-18)11-13-33-31-24-19-7-2-3-8-21(19)29-25(24)23-20-15-17(27)9-10-22(20)30-26(23)32;1-30-11-9-17(10-12-30)31(2)13-14-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-15-16(26)7-8-21(19)28-25(22)32;1-15(2)10-11-29(3)12-13-31-28-22-17-6-4-5-7-19(17)26-23(22)21-18-14-16(25)8-9-20(18)27-24(21)30;1-28(2)10-11-29(3)12-13-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-14-15(24)8-9-19(17)26-23(20)30/h3-6,11-12,15-18,30,32H,7-10,13-14H2,1-2H3;2-10,12,15-16,30,32H,11,13-14H2,1H3;3-8,15,17,28,32H,9-14H2,1-2H3;4-9,14-15,27,30H,10-13H2,1-3H3;4-9,14,26,30H,10-13H2,1-3H3/p+1/b31-25+;31-24+;29-23+;28-22+;27-21+
InChIKeyIFVICHNYNKEXCB-NNMPHZAYSA-O
XLogP26.05
TPSA380.14 Ų
H-Bond Donors11
H-Bond Acceptors25
Rotatable Bonds35
Heavy Atoms161
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002491.11
LogP ≤ 526.05
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_imine_A(9)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-bromo-3-[(3E)-3-[2-[methyl(pyridin-2-ylmethyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 136387397
5-bromo-3-[3-[2-[methyl(pyridin-2-ylmethyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 137048854
2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(pyridin-2-ylmethyl)azanium
CID 148007593
5-bromo-3-[(3E)-3-(2-cyclohexylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-piperidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol;methane
CID 157186105
5-bromo-3-[2-(7-ethyl-2-azabicyclo[2.2.2]oct-5-en-2-yl)ethyl]-1H-indole;3-[2-(7-ethyl-2-azabicyclo[2.2.2]oct-5-en-2-yl)ethyl]-5-fluoro-1H-indole;[3-[2-(7-ethyl-2-azabicyclo[2.2.2]oct-5-en-2-yl)ethyl]-1H-indol-5-yl]methanol;3-[2-(7-ethyl-2-azabicyclo[2.2.2]oct-5-en-2-yl)ethyl]-5-methyl-1H-indole;3-[2-(7-propan-2-yl-2-azabicyclo[2.2.2]oct-5-en-2-yl)ethyl]-1H-indole
CID 159457936
5-bromo-3-[(3E)-3-(2-cyclohexylethoxyimino)indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(2-piperidin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol
CID 161272715
5-bromo-3-[3-[4-[2-(dimethylamino)ethyl-methylamino]butoxyimino]indol-2-yl]-1H-indol-2-ol;4-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxybutyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[2-(3-methylcyclohexyl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[4-[methyl(propyl)amino]butoxyimino]indol-2-yl]-1H-indol-2-ol
CID 164979408
5-bromo-3-[3-[2-(4-methylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(1-methylpiperidin-1-ium-4-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;bis(5-bromo-3-[3-[2-[4-(2-propoxyethyl)piperazin-1-yl]ethoxyimino]indol-2-yl]-1H-indol-2-ol);5-bromo-3-[3-[2-(4-propylpiperazin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(1-propylpiperidin-4-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 167589450
5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl(3-methylbutyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(2-methylpiperidin-4-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl(propyl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 167608107
5-bromo-3-[3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-[2-(3-methylpiperidin-1-yl)ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol
CID 167698295
5-bromo-3-[3-[2-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 169132897
5-bromo-3-[3-[2-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethoxyimino]indol-2-yl]-1H-indol-2-ol
CID 169132952

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?
The IUPAC name of 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol (CID 172961503) is 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol.
What is the SMILES notation for 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?
The canonical SMILES for 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol is CC(C)CC[NH+](C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CC(CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21)Cc1ccccn1.CC1CCC(C(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.CN(C)CCN(C)CCO/N=C1/C(c2c(O)[nH]c3ccc(Br)cc23)=Nc2ccccc21.CN1CCC(N(C)CCO/N=C2/C(c3c(O)[nH]c4ccc(Br)cc34)=Nc3ccccc32)CC1.
What is the InChIKey of 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?
The InChIKey is IFVICHNYNKEXCB-NNMPHZAYSA-O. The full InChI is InChI=1S/C27H30BrN3O2.C26H23BrN4O2.C25H28BrN5O2.C24H27BrN4O2.C23H26BrN5O2/c1-16-7-9-18(10-8-16)17(2)13-14-33-31-25-20-5-3-4-6-22(20)29-26(25)24-21-15-19(28)11-12-23(21)30-27(24)32;1-16(14-18-6-4-5-12-28-18)11-13-33-31-24-19-7-2-3-8-21(19)29-25(24)23-20-15-17(27)9-10-22(20)30-26(23)32;1-30-11-9-17(10-12-30)31(2)13-14-33-29-23-18-5-3-4-6-20(18)27-24(23)22-19-15-16(26)7-8-21(19)28-25(22)32;1-15(2)10-11-29(3)12-13-31-28-22-17-6-4-5-7-19(17)26-23(22)21-18-14-16(25)8-9-20(18)27-24(21)30;1-28(2)10-11-29(3)12-13-31-27-21-16-6-4-5-7-18(16)25-22(21)20-17-14-15(24)8-9-19(17)26-23(20)30/h3-6,11-12,15-18,30,32H,7-10,13-14H2,1-2H3;2-10,12,15-16,30,32H,11,13-14H2,1H3;3-8,15,17,28,32H,9-14H2,1-2H3;4-9,14-15,27,30H,10-13H2,1-3H3;4-9,14,26,30H,10-13H2,1-3H3/p+1/b31-25+;31-24+;29-23+;28-22+;27-21+.
What are the key properties of 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol?
5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol has a molecular weight of 2491.11 g/mol, XLogP of 26.05, 35 rotatable bonds, 11 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-[(3E)-3-[2-[2-(dimethylamino)ethyl-methylamino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;2-[(E)-[2-(5-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino]oxyethyl-methyl-(3-methylbutyl)azanium;5-bromo-3-[(3E)-3-[3-(4-methylcyclohexyl)butoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-[2-[methyl-(1-methylpiperidin-4-yl)amino]ethoxyimino]indol-2-yl]-1H-indol-2-ol;5-bromo-3-[(3E)-3-(3-methyl-4-pyridin-2-ylbutoxy)iminoindol-2-yl]-1H-indol-2-ol is sourced from PubChem (CID 172961503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).